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ABSTRACT
Objective: This present study aimed to evaluate the anticoagulant activity and antioxidant properties of Prasaplai recipe (PPR), a Thai traditional 
medicine, and its major ingredient, Zingiber cassumunar (ZC) Roxb. extracts, seeking new therapeutic purposes for the recipe.
Methods: Aqueous extracts of PPR and ZC Roxb. were prepared by hot water decoction technique. The anticoagulant activity of the extracts was 
evaluated by prothrombin time (PT) and activated partial thromboplastin time (APTT) tests. In addition to anticoagulant activity, total phenol 
content and antioxidant activity were investigated. Total phenol content was determined using the Folin–Ciocalteu assay. The antioxidant activity was 
estimated by DPPH radical scavenging activity and ferric reducing antioxidant power assay.
Results: The APTT of plasma samples mixed with the PPR and ZC Roxb. extracts was significantly prolonged (p<0.05) at the concentration of 
1.0 mg/ml and above comparing to the control (normal saline solution) but was no significantly different for the PT. These results suggested that 
PPR and ZC Roxb. extracts showed anticoagulant activity affecting the function of coagulation factor in the intrinsic pathway. All aqueous extracts 
possessed considerable antioxidant activity and were rich in total polyphenol.
Conclusion: This finding indicates that the aqueous extracts possess significant anticoagulant and antioxidant activities, thus showing the potential 
PPR and ZC Roxb. as a new source of bioactive compounds for therapeutic purposes, with particular emphasis on the prevention and treatment of 
thrombosis.
Keywords: Prasaplai, Zingiber cassumunar Roxb., Coagulation, Antioxidant, Total phenol content, Thrombosis.
INTRODUCTION
Thai traditional herbal medicines are used for the treatment of various 
symptoms and diseases [1]. Buddhism believes that imbalance in 
one of four elements; earth, water, wind, and fire, within the human 
body could lead to illness. Zingiber cassumunar (ZC) Roxb. known as 
Plai, is one of the Thai herbal formulas which is used for restoring 
body elemental balance [2]. It is used for the treatment of menstrual 
disorders, flow enhancement of the discarded uterine blood after birth, 
wound healing, muscle and joint pain, skin diseases, inflammation, and 
abscesses [3]. ZC Roxb. is a major component of the Prasaplai recipe, a 
Thai traditional medicine formula, which has been used to relieve pain 
from the primary dysmenorrhea, regulates irregular menstrual flow, 
and driving out the discarded uterine blood after birth [2,4]. Prasaplai 
recipe has been listed in the Thai traditional common household drug 
list since 2006 [5]. To reduce pain, 1000mg orally 3 times a day before 
meals is recommended. This method is approved by the National Drug 
List of Herbal Medicinal Products AD 2008 [4]. The previous in vitro 
studies reported that Prasaplai recipe (PPR) acts as COX inhibitors 
which can help diminish pain from the primary dysmenorrheal [6].
Thrombosis is the condition of blood clot formation inside a vein or 
artery vessel that blocks the blood flow. If it slips from the vessel wall, 
it could obstruct in the organs causing heart and vascular diseases 
such as ischemic heart disease [7] and cerebrovascular disease [8]. 
A blood clot forms when there is an imbalance in the blood coagulation 
system, leading to several serious health conditions, for instance, 
venous thromboembolism which can cause deep vein thrombosis and/
or pulmonary embolism [9]. The treatment for blood clot embolism 
involves antiplatelet, anticoagulant, or thrombolytic medications. 
Anticoagulants, heparin, and warfarin are the main medications given 
for the prevention of blood clotting, whereas thrombolytic agents such 
as streptokinase dissolve the clot [9].
The previous studies have suggested that the consumption of 
antioxidant-rich foods might be important in preventing oxidative 
stress-induced platelet activation and aggregation, resulting in 
attenuating adverse hemostatic function [10]. Nowadays, therefore, 
much effort has been focused on natural products including medicinal 
plants, fruits, and vegetables, as antithrombotic agents [11]. The main 
reasons for using natural products are that they usually have less side 
effects on the body and comprise multiple constituents which each may 
have multiple targets increasing the therapeutic efficacy [12].
As their Thai traditional medicinal properties, including regulating 
irregular menstrual flow and enhancing the discarded uterine blood 
flow after birth, Prasaplai recipe and ZC Roxb. may affect the coagulation 
mechanism. Therefore, the present study was carried out aiming to 
evaluate their anticoagulant activity and antioxidant properties.
MATERIALS AND METHODS
Plant materials
Plant materials were purchased from a traditional herb market 
at Pathum Thani Province, Thailand. PPR was prepared from 12 
components including 50% of the rhizomes powder of ZC Roxb. (81 
parts), each eight parts of Citrus hystrix DC. (peel), Acorus calamus L. 
(root), Allium sativum L. (bulb), Eleutherine americana Merr. (bulb), 
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Piper nigrum L. (fruit), Piper retrofractum Vahl. (fruit), Zingiber 
officinale Roxb. (rhizome), Curcuma zedoaria Roscoe. (rhizome), and 
Nigella sativa L. (seed), and two chemical compounds which are sodium 
chloride (8 parts) and camphor (1 part) [13].
Extraction of plant material
The extractions were performed by decoction technique, using boiling 
with distilled water [14]. The powder portion of PPR or ZC Roxb. 
(10% w/v) was soaked in boiling distilled water for 30 min at room 
temperature with occasional stirring. The solution was filtrated through 
Whatman‎ filter‎ paper No.1 and was then concentrated by lyophilization. 
The crude extracts of PPR and ZC Roxb. were kept in desiccators 
until used. For testing of anticoagulant activity in blood samples, the 
prothrombin time (PT) and activated partial thromboplastin time 
(APTT) tests were employed.
Blood samples
Peripheral blood samples were collected from 10 healthy human 
volunteers (five males and five females, aged 19–35 years). Volunteers 
had no history of oral contraceptive or anticoagulant therapy. The 
blood placed separately in containers containing 3.2% sodium citrate. 
Centrifugation was carried out at 1000×g for 20 min at 4°C, to separate 
the blood cells from plasma to obtain platelet-poor plasma (PPP). 
The PPP was employed for PT and APTT tests. The study design and 
informed consent form for the volunteers were approved by the 
Committee on Human Rights Related to Human the Experimentation of 
Western University, Kanchanaburi 70170, Thailand (reference number 
WTU2557-00172).
PT and APTT testing
To determine the extrinsic and intrinsic coagulant activity, the PPP was 
mixed with each extract solution (0.5–4.0 mg/ml) at a ratio of 1:1 v/v [15]. PT 
and APTT were determined in the mixtures by Neoplastine® CI Plus and 
C.K. Prest® reagents (Diagnostica Stago S.A.S., France), respectively, 
according to manufacturer’s instructions using the URIT-600 
Coagulation analyzer (URIT Medical Electronic Co. Ltd., China). Normal 
saline solution (NSS) (0.85% w/v NaCl, NSS) was used for the negative 
control. PT and APTT results are expressed in second (s). International 




ISIPT samplePT / INR =
PT control
Where, ISI=International sensitivity index (1.28)
Normal INR=0.9–1.2.
Total phenolic content determination
Total phenolic content was determined using a Folin–Ciocalteu 
method [16]. About 100 µl of 1:10 Folin–Ciocalteu reagent dilution and 
10 µl of the sample were added into 96-well microplate. The microplate 
was incubated at room temperature for 7 min. About 80 µl of 1.0 M 
Na2CO3 was added and then the solution was left at room temperature 
for 2 h. The absorbance was measured at 750 nm using a microplate 
reader (Glomax-Multi Detection System, USA). The total phenolic 
content of the extract was calculated with a linear regression equation 
obtained from the gallic acid standard curve. Results were expressed as 
mg of gallic acid equivalent/g extract.
DPPH radical scavenging activity
The DPPH free radical scavenging was measured [17]. The 0.2 mM 
solution of DPPH in methanol was prepared and 100 µl of this solution 
was added to 100 µl of ZC Roxb., Prasaplai, and a reference compound, 
ascorbic acid. After 30 min, absorbance was measured at 520 nm using a 
microplate reader (Glomax-Multi Detection System, USA). All tests were 
performed in triplicate. The percentage of inhibition was determined 
by comparing the absorbance values of control and extracts.
A control - A sample% DPPH inhibition = ×100
A control
Ferric reducing antioxidant power (FRAP) assay
The assay based on the reduction of ferric-tripyridyltriazine (Fe3+-TPTZ) 
to a blue-colored ferrous tripyridyltriazine (Fe2+-TPTZ) [18]. The 20 µl of 
the extract was added to 150 µl of the FRAP reagent and then incubated 
at 37°C for 4 min. The absorbance of solutions was measured at 600 nm 
using a microplate reader (Glomax-Multi Detection System, USA). 
With 1 mM FeSO4 solution as standard, FRAP value of the sample was 
expressed as µM, using linear calibration obtained with the different 
concentration of FeSO4.
Statistical analysis
The data obtained were analyzed using GraphPad Prism 6 version 6.01 
(GraphPad Software Inc. La Jolla, CA, USA). All values are expressed as 
mean ± standard deviation for three replicates. Data were analyzed 
by the one-way analysis of variance and the statistically significant 
differences were analyzed using a paired sample t-test. Value of p<0.05 
was considered to be statistically significant.
RESULTS AND DISCUSSION
Anticoagulant activity
The in vitro anticoagulant activity of the crude extracts of PPR and ZC 
Roxb. was evaluated by PT and APTT assays using pooled normal human 
plasma. The crude extract of PPR was evaluated for anticoagulant activity 
at the concentrations of 0.5, 1.0, 2.0, and 4.0 mg/m1 while the extract 
of ZC Roxb. was determined for anticoagulant activity at the selected 
concentration, 1.0 mg/ml (Table 1). The APTT and PT baseline values of 
pooled plasma were 34.87±0.45 and 11.80±0.17 s, respectively. The APTT 
and PT values of NSS vehicle control were 41.70±1.13 and 17.37±0.40 s, 
respectively. The effect of the extracts on the APTT and PT testing 
was measured to evaluate anticoagulant activity against the extrinsic 
and intrinsic coagulation pathways. The PT results showed that 
PPR extract at concentrations of 0.5, 1.0, 2.0, and 4.0 mg/ml was 
18.23±0.45, 17.57±0.31, 17.40±0.10, and 17.90±0.10 s, respectively, 
while ZC Roxb. at the concentration of 1.0 mg/ml was 18.10±0.52 s. 
The PT obtained in the presence of all concentration of the extracts 
was not significantly different (p>0.05) when compared to NSS control 
(Fig. 1). The APTT of PPR extracts at concentrations of 0.5, 1.0, 2.0, and 
4.0 mg/ml was 44.93±2.19, 45.87±0.70, 47.53±1.57, and 48.23±1.38 s, 
respectively, while ZC Roxb. extract (1.0 mg/ml) was 50.17±1.11 s. PPR 
at concentration of 1.0 to 4.0 mg/ml and ZC Roxb. (1.0 mg/ml) showed 
a highly significant difference compared to NSS control (Fig. 2). PT 
and APTT values of PPR at concentration of 0.5 mg/ml did not show a 
significant difference when compared to NSS control (p>0.05) as shown 
in Table 1.
Fig. 1: Effect of PPR and ZC Roxb. extracts on prothrombin time 
compared with NSS. NSS: Normal saline solution, ZC: Zingiber 
cassumunar Roxb. (Plai), PPR: Prasaplai recipe
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The coagulation system involves a complex set of reactions involving 
many different proteins [19]. These reactions convert fibrinogen 
to fibrin, which forms a thrombus with platelets. The initiation of 
coagulation cascades is divided into two parts, intrinsic and extrinsic 
coagulation pathways. The extrinsic coagulation pathway is responsible 
for the initial generation of activated factor X (Factor Xa), which is 
induced by the factor VIIa/tissue factor complex. The intrinsic pathway 
composes of coagulation factors XII, XI, IX, and VIII. The activation 
of the intrinsic pathway leads to amplification of factor Xa, which 
plays a central role in the coagulation cascade, called the common 
pathway [19]. The APTT and PT tests evaluate the ability to produce 
a blood clot in a reasonable amount of time and, if any of these factors 
are inhibited, the test results will be prolonged. The APTT evaluates 
coagulation factors VIII, IX, XI, and XII in the intrinsic coagulation 
pathway while the PT test is employed to evaluate the extrinsic clotting 
factors including coagulation factor VII. Moreover, these two tests 
also evaluate a common pathway involving factors I, II, V, and X of the 
clotting cascade. From our study, ZC Roxb. and PPR extracts were able 
to prolong APTT in a concentration-dependent manner, demonstrating 
its anticoagulant activity. In the PT test, no prolongation of the clotting 
time was observed. The prolongation of APTT, but not PT, indicates the 
inhibition of coagulation factor in the intrinsic coagulation pathway [20]. 
The present results suggest that ZC Roxb. and PPR inhibit preferentially 
intrinsic pathways of coagulation. The anticoagulant activity of the 
extracts against factors VIII, IX, XI, or XII was suspected. Since both PPR 
and ZC Roxb. exhibited anticoagulation activity through inhibition of 
coagulation factor in the intrinsic coagulation pathway, anticoagulant 
properties of PPR could be the active compound derived from ZC 
Roxb. which is the major ingredient of the formula. Phytochemical 
investigations of ZC Roxb. rhizomes have revealed the presence of 
α-pinene, β-pinene, sabinene, γ-terpinene, terpine-4-ol [21], (E)-1-(3,4-
dimethoxyphenyl) butadiene [22], naphthoquinones, phenylbutanoids, 
cyclohexene derivatives, vanillic acid, vanillin, veratric acid, terpenoids, 
curcuminoids, and β-sitosterol [23]. However, there are no direct 
studies of anticoagulation properties in individual compounds. The 
antithrombolytic activities of other components of Prasaplai formula 
have been reported. A. sativum L. suppresses the coagulation system 
by downregulating thrombin formation. Moreover, increased levels 
of thrombin-antithrombin III (TAT) complex, which induced by A. 
sativum L., can cause the prolongation of both PT and APTT tests 
[24]. In this study, however, the prolongation of PT was not detected 
in normal plasma which was treated with the aqueous extract of PPR. 
This could be probably explained by either the low concentration of 
active compound from the minor proportion of A. sativum L. in the PPR 
or the extraction method was used cannot properly extract the active 
compound from the recipe . In agreement with our results, some herbs, 
for instance, the aqueous extract of Jatropha gossypifolia L. showed 
anticoagulant activity against intrinsic coagulation pathway at the 
range of concentrations of 0.5–2.0 mg/ml [25]. Besides, the aqueous 
extracts from both PPR and ZC Roxb. revealed anticoagulant activity, 
our previous study showed that the extracts exhibited moderate 
thrombolytic activity [26]. Therefore, PPR and ZC Roxb. could potential 
antithrombotic properties. On the other hand, these results suggest 
avoiding the use of PPR and ZC Roxb. in patients who are considered to 
be high risk for bleeding.
Total phenol content
The total phenolic content of the extracts is shown in Table 2. These 
results demonstrated that total phenol content in the aqueous 
solvent of ZC Roxb. and PPR was uniform. There are evidence of 
positive association between total phenol content and the antioxidant 
properties. Gorinstein et al. [27] and Hodzic et al. [28] showed strong 
correlations between total phenolic content and antioxidant activity. 
They also demonstrated that the amount of total phenolic content could 
affect the antioxidant capacity. Their results displayed linear correlation 
between the amount of total phenolic content and antioxidant capacity 
where high total phenol content provides high antioxidant capacity.
DPPH free radical scavenging activity
DPPH radical scavenging activity by antioxidant is attributable to their 
hydrogen donating activity. The results showed that the percentage 
inhibition of 1 mg/ml of the aqueous extract of Prasaplai extract had a 
higher DPPH radical scavenging activity than ZC Roxb. extract (Table 2). 
Table 1: Anticoagulant activities of ZC Roxb. and PPR extracts
Sample APTTa (s) p‑value PTa (s) p‑value PT/INR
Baseline 34.87±0.45 - 11.80±0.17 - -
NSS 41.70±1.13 - 17.37±0.40 - -
ZC 1.0 mg/ml 50.17±1.11 0.0007*** 18.10±0.52 0.1259 1.05
PPR 0.5 mg/ml 44.93±2.19 0.0857 18.23±0.45 0.0683 1.06
PPR 1.0 mg/ml 45.87±0.70 0.0056** 17.57±0.31 0.5317 1.01
PPR 2.0 mg/ml 47.53±1.57 0.0064** 17.40±0.10 0.8964 1.00
PPR 4.0 mg/ml 48.23±1.38 0.0031** 17.90±0.10 0.0907 1.04
amean±SD, **p<0.01, ***p<0.001, compared with NSS, ZC: Zingiber cassumunar Roxb. (Plai), NSS: Normal saline solution, PPR: Prasaplai recipe, APTT: Activated partial 
thromboplastin time
Table 2: Total phenolic content, DPPH inhibition, and FRAP values of Prasaplai recipe and Zingiber cassumunar Roxb. extracts
Plant Total phenolic contenta (mg GAE/g extract) DPPH inhibitiona (%) FRAP valuea (µM)
Prasaplai recipe 43.93±0.42 77.14±0.36 1,032.38±2.21
Zingiber cassumunar Roxb. 42.00±0.45 73.11±3.80 990.46±2.46
aAll data were expressed in mean±SD (n=3). GAE: Gallic acid equivalent, FRAP: Ferric reducing antioxidant power
Fig. 2: Effect of Prasaplai recipe and ZC Roxb. extracts on activated 
partial thromboplastin time, **p<0.01, ***p<0.001, compared 
with NSS.  NSS: Normal saline solution, ZC: Zingiber cassumunar 
Roxb. (Plai), PPR: Prasaplai recipe
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The DPPH radical scavenging activity was significantly positively 
correlated (p<0.001) with the total phenolic content. The results were 
in agreement with the previous research results from Wu et al. [29] and 
Yang et al. [30].
FRAP value
The FRAP value of aqueous extract of ZC Roxb. and PPR was significantly 
different (p=0.02), and the FRAP value of Prasaplai extract was higher than 
ZC Roxb. extract. ZC Roxb. extract has FRAP value of 990.46±2.46 µM/g 
sample and the Prasaplai extract with 1032.38±2.21 µM/g sample 
(Table 2). Based on reducing ferric ion in FRAP assay, higher FRAP 
value could reflect higher antioxidant activity [31]. Moreover, there was 
a positive correlation between the antioxidant activity and the total 
phenolic content in ZC Roxb. and PPR. This may indicate that the phenols 
in ZC Roxb. played an important role in antioxidant activity.
As the positive correlation between the antioxidant activity and the 
total phenolic content was observed in the extracts from PPR and its 
main ingredient, ZC Roxb., this may indicate that the phenols play an 
important role in antioxidant activity. Antioxidants are compounds that 
can donate single electron for reduction and consequently terminate 
the attack of free radicals, resulting in prevention of cell and tissue 
damage [32]. There are many factors affecting the extraction of 
antioxidant compounds from plants. The solvent used is an important 
factor to extract antioxidant compounds in plant materials due to their 
different polarity characteristics [33]. Therefore, different methods of 
extraction or other solvents such as methanol, ethanol, and acetone 
should be considered for PPR and ZC Roxb. extraction. Moreover, quality 
of extracts and antioxidant activities are also depend on geographic 
origin, harvesting season, and storage conditions [33].
CONCLUSION
We have described the in vitro anticoagulant activity of aqueous 
extracts from PPR and ZC Roxb., which are beneficial in Thai traditional 
medicine. Both extracts dose-dependently prolonged the APTT, 
suggesting that the extracts exhibit anticoagulant activity correlating 
with the intrinsic coagulation pathway. In addition to the anticoagulant 
activity, the extracts also proved to be a good source of antioxidant 
compounds. Since compounds with anticoagulant and antioxidant 
could be used for antithrombotic treatment, we suggest that based on 
our results, the aqueous extract of PPR and ZC Roxb. shows promising 
potential as a future therapeutic agent. Further work has to been done 
for isolation, characterization, and mechanism of action of the active 
phytochemical constituents from the herb, to establish an effective drug 
resource for prevention and treatment of disease caused by thrombosis.
ACKNOWLEDGMENTS
The authors would like to thank the financial support (Grant no. 
NRF04115804) from Thai traditional medicine college, Rajamangala 
University of Technology Thanyaburi, and the financial support (Grant 
no. WU60307) from Walailak University, Nakhon Si Thammarat, 
Thailand.
CONFLICTS OF INTEREST
All authors have none to declare.
REFERENCES
1. Subcharoen P. Thai traditional medicine in the new millennium. J Med 
Assoc Thai 2004;87 Suppl 4:S52-7.
2. Vannabhum M, Poopong S, Wongwananuruk T, Nimmannit A, 
Suwannatrai U, Dangrat C, et al. The efficacy of Thai herbal prasaplai 
formula for treatment of primary dysmenorrhea: A short-term 
randomized controlled trial. Evid Based Complement Alternat Med 
2016;2016:2096797.
3. Farnsworth NR, Bunyapraphatsara N. Thai Medicinal Plants: 
Recommended for Primary Health Care System. Bangkok: Medicinal 
Plant Information Center; 1992.
4. Department for Development of Thai Traditional and Alternative 
Medicine. List of Herbal Medicinal Product A.D 2008. Bangkok: 
Ministry Public Health; 2008.
5. Department for Development of Thai Traditional and Alternative 
Medicine. List of Herbal Medicinal Product A.D 2006. Bangkok: 
Ministry Public Health; 2006.
6. Lee W, Yoo H, Ku SK, Kim JA, Bae JS. Anticoagulant activities of 
piperlonguminine in vitro and in vivo. BMB Rep 2013;46:484-9.
7. Ambrose JA, Weinrauch M. Thrombosis in ischemic heart disease. 
Arch Intern Med 1996;156:1382-94.
8. Gorelick PB. Cerebrovascular disease. Pathophysiology and diagnosis. 
Nurs Clin North Am 1986;21:275-88.
9. Waldo AL. Anticoagulation: Stroke prevention in patients with atrial 
fibrillation. Cardiol Clin 2009;27:125-35, ix.
10. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. The role of 
polyphenolic compounds in the diet as inhibitors of platelet function. 
Proc Nutr Soc 2003;62:469-78.
11. Slevin M, Ahmed N, Wang Q, McDowell G, Badimon L. Unique 
vascular protective properties of natural products: Supplements or 
future main-line drugs with significant anti-atherosclerotic potential? 
Vasc Cell 2012;4:9.
12. Fuentes E, Palomo I. Antiplatelet effects of natural bioactive 
compounds by multiple targets: Food and drug interactions. J Funct 
Foods 2014;6:73-81.
13. Gritsanapan W, Tangyuenyongwatana P. Standardization of prasaplai, a 
Thai traditional preparation for antidysmenorrhea. Botanics 2016;6:1-9.
14. Daswani PG, Ghadge AA, Brijesh S, Birdi TJ. Preparation of decoction 
of medicinal plants: A self-help measure? J Altern Complement Med 
2011;17:1099-100.
15. Khan H, Khan MA, Mahmood T, Choudhary MI. Antimicrobial 
activities of Gloriosa superba Linn (Colchicaceae) extracts. J Enzyme 
Inhib Med Chem 2008;23:855-9.
16. John B, Sulaiman CT, George S, Reddy VR. Total phenolics and 
flavonoids in selected medicinal plants from Kerala. Int J Pharm Pharm 
Sci 2014;6:406-8.
17. Sanna D, Delogu G, Mulas M, Schirra M, Fadda A. Determination of 
free radical scavenging activity of plant extracts through DPPH assay: 
An EPR and UV-vis study. Food Anal Method 2012;5:759-66.
18. Rabeta MS, Faraniza RN. Total phenolic content and ferric reducing 
antioxidant power of the leaves and fruits of Garcinia atrovirdis and 
Cynometra cauliflora. Int Food Res J 2013;20:1691-6.
19. Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J 
Anaesth 2014;58:515-23.
20. Mao W, Li H, Li Y, Zhang H, Qi X, Sun H, et al. Chemical characteristic 
and anticoagulant activity of the sulfated polysaccharide isolated 
from Monostroma latissimum (Chlorophyta). Int J Biol Macromol 
2009;44:70-4.
21. Casey TE, Dougan J, Matthews WS, Nabney J. Essential oil of “phlai” 
Zingiber cassumunar Roxb. from Thailand. Trop Sci 1971;13:199-202.
22. Tangyuenyongwatana P, Keeratinijakal V, Gritsanapani W. Thin-layer 
chromatography-densitometry analysis of dimethoxyphenylbutadiene 
content in Zingiber cassumunar rhizomes. J AOAC Int 
2012;95:1614-7.
23. Bhuiyan MN, Chowdhury JU, Begum J. Volatile constituents of 
essential oils isolated from leaf and rhizome of Zingiber cassumunar 
Roxb. Bangl J Pharmacol 2008;3:69-73.
24. Fukao H, Yoshida H, Tazawa Y, Hada T. Antithrombotic effects of 
odorless garlic powder both in vitro and in vivo. Biosci Biotechnol 
Biochem 2007;71:84-90.
25. Félix-Silva J, Souza T, Camara RB, Cabral B, Silva-Júnior AA, 
Rebecchi IM, et al. In vitro anticoagulant and antioxidant activities of 
Jatropha gossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical 
applications. BMC Complement Altern Med 2014;14:405.
26. Khobjai W, Sukati S, Jarmkom K, Eakwaropas P, Techaoei S. 
Evaluation of thrombolytic activity of Zingiber cassumunar Roxb. and 
Thai herbal prasaplai formula. World Acad Sci Eng Technol Int J Med 
Health Biomed Bioeng Pharm Eng 2017;11:268-71.
27. Gorinstein S, Zachwieja Z, Katrich E, Pawelzik E, Haruenkit R, 
Trakhtenberg S, et al. Comparison of the contents of the main 
antioxidant compounds and the antioxidant activity of white grapefruit 
and his new hybrid. LWT Food Sci Technol 2004;37:337-43.
28. Hodzic Z, Pasalic H, Memisevic A, Srabovic M, Saletovic M, 
Poljakovic M. The influence of the total phenols content on antioxidant 
capacity in the whole grain extracts. Eur J Sci Res 2009;28:471-7.
29. Wu LC, Hsu HW, Chen YC, Chiu CC, Lin YI, Ho JA. Antioxidant and 
antiproliferative activities of red pitaya. Food Chem 2006;95:319-27.
30. Yang D, Zhang Q, Ren G, Ying T. A comparative study on antioxidant 
activity of different parts of lotus (Nelumbo nuficera Gaertn) rhizome. 
Int J App Pharm, Vol 11, Special Issue 5, 2019
 Sukati et al. 
 4th International Conference on Pharmacy and Pharmaceutical Science (ICPPS) 2019 30
Food Sci Technol (Campinas) 2007;37:135-7.
31. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as 
a measure of “antioxidant power”: The FRAP assay. Anal Biochem 
1996;239:70-6.
32. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity 
relationships of flavonoids and phenolic acids. Free Radic Biol Med 
1996;20:933-56.
33.	 Moure	A,	Franco	D,	Sineiro	J,	Domı́nguez H, Núñez MJ, Lema JM. 
Antioxidant activity of extracts from Gevuina avellana and Rosa 
rubiginosa defatted seeds. Food Res Int 2001;34:103-9.
